{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:56:44Z","timestamp":1760551004251},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s00432-003-0435-9","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:27:54Z","timestamp":1576121274000},"page":"287-294","source":"Crossref","is-referenced-by-count":23,"title":["Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131"],"prefix":"10.1007","volume":"129","author":[{"given":"Marcel P. M.","family":"Stokkel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henna I. E.","family":"Reigman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbert B. T.","family":"Verkooijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan W.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,5,15]]},"reference":[{"key":"0435_CR1","first-page":"1857","volume":"82","author":"Ain","year":"1997","unstructured":"Ain KB, Taylor KD, Tofiq S, Venkataraman G (1997) Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab 82:1857\u20131862","journal-title":"J Clin Endocrinol Metab"},{"key":"0435_CR2","first-page":"2541","volume":"81","author":"Baudin","year":"1996","unstructured":"Baudin E, Schlumberger M, Lumbroso J, Travagli JP, Caillou B, Parmentier C (1996) Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. J Clin Endocrinol Metab 81:2541\u20132544","journal-title":"J Clin Endocrinol Metab"},{"key":"0435_CR3","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jcem.86.4.7390","volume":"86","author":"Bernier","year":"2001","unstructured":"Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G (2001) Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568\u20131573","journal-title":"J Clin Endocrinol Metab"},{"key":"0435_CR4","first-page":"1515","volume":"29","author":"Brendel","year":"1988","unstructured":"Brendel AJ, Guyot M, Jeandot R, Lefort G, Manciet G (1988) Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma. J Nucl Med 29:1515\u20131520","journal-title":"J Nucl Med"},{"key":"0435_CR5","first-page":"1626","volume":"34","author":"Casara","year":"1993","unstructured":"Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, Busnardo B (1993) Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626\u20131631","journal-title":"J Nucl Med"},{"key":"0435_CR6","first-page":"1841","volume":"42","author":"de","year":"2001","unstructured":"de Jong M, Breeman WA, Bernard BF, Bakker WH, Visser TJ, Kooij PP, van Gameren A, Krenning EP (2001) Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size. J Nucl Med 42:1841\u20131846","journal-title":"J Nucl Med"},{"key":"0435_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/snuc.2002.31027","volume":"32","author":"de","year":"2002","unstructured":"de Jong M, Valkema R, Jamar F, Kvols LK, Kwekkeboom DJ, Breeman WA, Bakker WH, Smith C, Pauwels S, Krenning EP (2002) Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings. Semin Nucl Med 32:133\u2013140","journal-title":"Semin Nucl Med"},{"key":"0435_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0038-1629852","volume":"37","author":"M Dietlein","year":"1998","unstructured":"Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H (1998) Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm? Nuklearmedizin 37:12\u201317","journal-title":"Nuklearmedizin"},{"key":"0435_CR10","first-page":"1468","volume":"37","author":"Feine","year":"1996","unstructured":"Feine U, Lietzenmayer R, Hanke JP, Held J, Wohrle H, Muller-Schauenburg W (1996) Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37:1468\u20131472","journal-title":"J Nucl Med"},{"key":"0435_CR12","first-page":"636","volume":"41","author":"Forssell-Aronsson","year":"2000","unstructured":"Forssell-Aronsson EB, Nilsson O, Bejegard SA, Kolby L, Bernhardt P, Molne J, Hashemi SH, Wangberg B, Tisell LE, Ahlman H (2000) 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors. J Nucl Med 41:636\u2013642","journal-title":"J Nucl Med"},{"key":"0435_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s002590050270","volume":"25","author":"Garin","year":"1998","unstructured":"Garin E, Devillers A, Le Cloirec J, Bernard AM, Lescouarc'h J, Herry JY, Reubi JC, Bourguet P (1998) Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. Eur J Nucl Med 25:687\u2013694","journal-title":"Eur J Nucl Med"},{"key":"0435_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/105072501750362718","volume":"11","author":"G\u00f6rges","year":"2001","unstructured":"G\u00f6rges R, Kahaly G, Muller-Brand J, Macke H, Roser HW, Bockisch A (2001) Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer. Thyroid 11:647\u2013659","journal-title":"Thyroid"},{"key":"0435_CR16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF00837630","volume":"23","author":"Grunwald","year":"1996","unstructured":"Grunwald F, Schomburg A, Bender H, Klemm E, Menzel C, Bultmann T, Palmedo H, Ruhlmann J, Kozak B, Biersack HJ (1996) Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 23:312\u2013319","journal-title":"Eur J Nucl Med"},{"key":"0435_CR17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF03351041","volume":"24","author":"Haslinghuis","year":"2001","unstructured":"Haslinghuis LM, Krenning EP, de Herder WW, Reijs AE, Kwekkeboom DJ (2001) Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer. J Endocrinol Invest 24:415\u2013422","journal-title":"J Endocrinol Invest"},{"key":"0435_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/(SICI)1098-2388(199901\/02)16:1<34::AID-SSU7>3.0.CO;2-2","volume":"16","author":"Haugen","year":"1999","unstructured":"Haugen BR (1999) Management of the patient with progressive radioiodine non-responsive disease. Semin Surg Oncol 16:34\u201341","journal-title":"Semin Surg Oncol"},{"key":"0435_CR19","first-page":"2638","volume":"81","author":"Hoelting","year":"1996","unstructured":"Hoelting T, Duh QY, Clark OH, Herfarth C (1996) Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo. J Clin Endocrinol Metab 81:2638\u20132641","journal-title":"J Clin Endocrinol Metab"},{"key":"0435_CR20","doi-asserted-by":"crossref","unstructured":"Krenning EP, Kooij PP, Pauwels S, Breeman WA, Postema PT, de Herder WW, Valkema R, Kwekkeboom DJ (1996) Somatostatin receptor: scintigraphy and radionuclide therapy. Digestion 57[Suppl 1]:57\u201361","DOI":"10.1159\/000201398"},{"key":"0435_CR21","doi-asserted-by":"crossref","unstructured":"Krenning EP, de Jong M, Kooij PP, Breeman WA, Bakker WH, de Herder WW, van Eijck CH, Kwekkeboom DJ, Jamar F, Pauwels S, Valkema R (1999) Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy. Ann Oncol 10[Suppl 2]: S23-S29","DOI":"10.1093\/annonc\/10.suppl_2.S23"},{"key":"0435_CR22","first-page":"3228","volume":"84","author":"Lazar","year":"1999","unstructured":"Lazar V, Bidart JM, Caillou B, Mahe C, Lacroix L, Filetti S, Schlumberger M (1999) Expression of the Na+\/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228\u20133234","journal-title":"J Clin Endocrinol Metab"},{"key":"0435_CR23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s002590050271","volume":"25","author":"Lin","year":"1998","unstructured":"Lin JD, Kao PF, Weng HF, Lu WT, Huang MJ (1998) Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma. Eur J Nucl Med 25:695\u2013700","journal-title":"Eur J Nucl Med"},{"key":"0435_CR24","first-page":"1487","volume":"37","author":"Lorberboym","year":"1996","unstructured":"Lorberboym M, Murthy S, Mechanick JI, Bergman D, Morris JC, Kim CK (1996) Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma. J Nucl Med 37:1487\u20131491","journal-title":"J Nucl Med"},{"key":"0435_CR26","first-page":"313","volume":"43","author":"Maxon","year":"1999","unstructured":"Maxon HR (1999) Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer. Q J Nucl Med 43:313\u2013323","journal-title":"Q J Nucl Med"},{"key":"0435_CR27","first-page":"88","volume":"44","author":"McCarthy","year":"2000","unstructured":"McCarthy KE, Woltering EA, Anthony LB (2000) In situ radiotherapy with 111In-pentetreotide. State of the art and perspectives. Q J Nucl Med 44:88\u201395","journal-title":"Q J Nucl Med"},{"key":"0435_CR28","first-page":"352","volume":"38","author":"Miyamoto","year":"1997","unstructured":"Miyamoto S, Kasagi K, Misaki T, Alam MS, Konishi J (1997) Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma. J Nucl Med 38:352\u2013356","journal-title":"J Nucl Med"},{"key":"0435_CR29","first-page":"807","volume":"39","author":"Nakada","year":"1998","unstructured":"Nakada K, Katoh C, Kanegae K, Tsukamoto E, Shiga T, Mochizuki T, Itoh K, Tamaki N (1998) Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma. J Nucl Med 39:807\u2013810","journal-title":"J Nucl Med"},{"key":"0435_CR30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01736992","volume":"23","author":"Nemec","year":"1996","unstructured":"Nemec J, Nyvltova O, Blazek T, Vlcek P, Racek P, Novak Z, Preiningerova M, Hubackova M, Krizo M, Zimak J, Bilek R (1996) Positive thyroid cancer scintigraphy using technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 23:69\u201371","journal-title":"Eur J Nucl Med"},{"key":"0435_CR31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1530\/eje.0.1370254","volume":"137","author":"Pachucki","year":"1997","unstructured":"Pachucki J, Burmeister LA (1997) Evaluation and treatment of persistent thyroglobulinemia in patients with well-differentiated thyroid cancer. Eur J Endocrinol 137:254\u2013261","journal-title":"Eur J Endocrinol"},{"key":"0435_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0969-8051(97)00226-6","volume":"25","author":"Pauwels","year":"1998","unstructured":"Pauwels EK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Maziere B (1998) FDG accumulation and tumor biology. Nucl Med Biol 25:317\u2013322","journal-title":"Nucl Med Biol"},{"key":"0435_CR33","doi-asserted-by":"crossref","unstructured":"Postema PT, de Herder WW, Reubi JC, Oei HY, Kwekkeboom DJ, Bruining HJ, Bonjer J, van Toor H, Hennemann G, Krenning EP (1996) Somatostatin receptor scintigraphy in non-medullary thyroid cancer. Digestion 57[Suppl 1]:36\u201337","DOI":"10.1159\/000201391"},{"key":"0435_CR35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002590050034","volume":"27","author":"Reubi","year":"2000","unstructured":"Reubi JC, Schar JC, Waser B, Wenger S, Heppeler A, Schmitt JS, Macke HR (2000) Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med 27:273\u2013282","journal-title":"Eur J Nucl Med"},{"key":"0435_CR37","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","volume":"28","author":"Reubi","year":"2001","unstructured":"Reubi JC, Waser B, Schaer JC, Laissue JA (2001) Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 28:836\u2013846","journal-title":"Eur J Nucl Med"},{"key":"0435_CR38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.2000.10.177","volume":"10","author":"Robbins","year":"2000","unstructured":"Robbins RJ, Hill RH, Wang W, Macapinlac HH, Larson SM (2000) Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogue. Thyroid 10:177\u2013183","journal-title":"Thyroid"},{"key":"0435_CR39","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s002590050111","volume":"24","author":"Roelants","year":"1997","unstructured":"Roelants V, Nayer PD, Bouckaert A, Beckers C (1997) The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer. Eur J Nucl Med 24:722\u2013727","journal-title":"Eur J Nucl Med"},{"key":"0435_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0753-3322(00)80060-8","volume":"54","author":"Rubello","year":"2000","unstructured":"Rubello D, Saladini G, Carpi A, Casara D (2000a) Nuclear medicine imaging procedures in differentiated thyroid carcinoma patients with negative iodine scan. Biomed Pharmacother 54:337\u2013344","journal-title":"Biomed Pharmacother"},{"key":"0435_CR41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s002590050527","volume":"27","author":"Rubello","year":"2000","unstructured":"Rubello D, Mazzarotto R, Casara D (2000b) The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med 27:431\u2013440","journal-title":"Eur J Nucl Med"},{"key":"0435_CR42","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00259-002-0871-9","volume":"29","author":"Rubello","year":"2002","unstructured":"Rubello D, Piotto A, Pagetta C, Pelizzo MR, Casara D (2002) (99m)Tc-MIBI radio-guided surgery for recurrent thyroid carcinoma: technical feasibility and procedure, and preliminary clinical results. Eur J Nucl Med Mol Imaging 29:1201\u20131205","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"0435_CR43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"Schlumberger","year":"1998","unstructured":"Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338:297\u2013306","journal-title":"N Engl J Med"},{"key":"0435_CR44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1530\/eje.0.1380249","volume":"138","author":"Schlumberger","year":"1998","unstructured":"Schlumberger M, Baudin E (1998) Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Eur J Endocrinol 138:249\u2013252","journal-title":"Eur J Endocrinol"},{"key":"0435_CR45","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/endo.140.11.7126","volume":"140","author":"Smith-Jones","year":"1999","unstructured":"Smith-Jones PM, Bischof C, Leimer M, Gludovacz D, Angelberger P, Pangerl T, Peck-Radosavljevic M, Hamilton G, Kaserer K, Kofler A, Schlangbauer-Wadl H, Traub T, Virgolini I (1999) DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy. Endocrinology 140:5136\u20135148","journal-title":"Endocrinology"},{"key":"0435_CR46","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1007\/s002590050501","volume":"26","author":"Stokkel","year":"1999","unstructured":"Stokkel MP, de Klerk JH, Zelissen PM, Koppeschaar HP, van Rijk PP (1999) Fluorine-18 fluorodeoxyglucose dual-head positron emission tomography in the detection of recurrent differentiated thyroid cancer: preliminary results. Eur J Nucl Med 26:1606\u20131609","journal-title":"Eur J Nucl Med"},{"key":"0435_CR47","first-page":"557","volume":"22","author":"Sundram","year":"1993","unstructured":"Sundram FX, Goh AS, Ang ES (1993) Role of technetium-99m sestamibi in localisation of thyroid cancer metastases. Ann Acad Med Singapore 22:557\u2013559","journal-title":"Ann Acad Med Singapore"},{"key":"0435_CR48","first-page":"453","volume":"39","author":"Uematsu","year":"1998","unstructured":"Uematsu H, Sadato N, Ohtsubo T, Tsuchida T, Nakamura S, Sugimoto K, Waki A, Takahashi N, Yonekura Y, Tsuda G, Saito H, Hayashi N, Yamamoto K, Ishii Y (1998) Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med 39:453\u2013459","journal-title":"J Nucl Med"},{"key":"0435_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0720-048X(99)00145-X","volume":"33","author":"van","year":"2000","unstructured":"van den Brekel MW (2000) Lymph node metastases: CT and MRI. Eur J Radiol 33:230\u2013238","journal-title":"Eur J Radiol"},{"key":"0435_CR50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0037-198X(00)80031-0","volume":"35","author":"van","year":"2000","unstructured":"van den Brekel MW, Castelijns JA (2000) Imaging of lymph nodes in the neck. Semin Roentgenol 35:42\u201353","journal-title":"Semin Roentgenol"},{"key":"0435_CR51","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/00006231-199512000-00001","volume":"16","author":"Van","year":"1995","unstructured":"Van Wyngaarden KE, Pauwels EK (1995) Fluorodeoxyglucose (FDG) and tumor metabolism. Nucl Med Commun 16:987\u2013989","journal-title":"Nucl Med Commun"},{"key":"0435_CR52","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1067\/msy.2001.115545","volume":"129","author":"Vassilopoulou-Sellin","year":"2001","unstructured":"Vassilopoulou-Sellin R (2001) Long-term outcome of children with papillary thyroid cancer. Surgery 129:769","journal-title":"Surgery"},{"key":"0435_CR53","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<493::AID-CNCR17>3.0.CO;2-U","volume":"78","author":"Vassilopoulou-Sellin","year":"1996","unstructured":"Vassilopoulou-Sellin R, Schultz PN, Haynie TP (1996) Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 78:493\u2013501","journal-title":"Cancer"},{"key":"0435_CR54","first-page":"153","volume":"45","author":"Virgolini","year":"2001","unstructured":"Virgolini I, Traub T, Novotny C, Leimer M, Fuger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Andreae F, Kurtaran A, Dudczak R (2001) New trends in peptide receptor radioligands. Q J Nucl Med 45:153\u2013159","journal-title":"Q J Nucl Med"},{"key":"0435_CR55","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2174\/1381612023393756","volume":"8","author":"Virgolini","year":"2002","unstructured":"Virgolini I, Traub T, Novotny C, Leimer M, Fuger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R (2002) Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Curr Pharm Des 8:1781\u20131807","journal-title":"Curr Pharm Des"},{"key":"0435_CR56","first-page":"1107","volume":"85","author":"Wang","year":"2000","unstructured":"Wang W, Larson SM, Fazzari M, Tickoo SK, Kolbert K, Sgouros G, Yeung H, Macapinlac H, Rosai J, Robbins RJ (2000) Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85:1107\u20131113","journal-title":"J Clin Endocrinol Metab"},{"key":"0435_CR57","first-page":"4973","volume":"52","author":"Weckbecker","year":"1992","unstructured":"Weckbecker G, Liu R, Tolcsvai L, Bruns C (1992) Antiproliferative effects of the somatostatin analogue octreotide (SMS 201\u2013995) on ZR-75\u20131 human breast cancer cells in vivo and in vitro. Cancer Res 52:4973\u20134978","journal-title":"Cancer Res"},{"key":"0435_CR58","doi-asserted-by":"crossref","unstructured":"Weckbecker G, Raulf F, Tolcsvai L, Bruns C (1996) Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo. Digestion 57[Suppl 1]:22\u201328","DOI":"10.1159\/000201388"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-003-0435-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-003-0435-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-003-0435-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T03:28:05Z","timestamp":1576121285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-003-0435-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["0435"],"URL":"https:\/\/doi.org\/10.1007\/s00432-003-0435-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}